Compartmental model of 18F-choline

Progress in Biomedical Optics and Imaging - Proceedings of SPIE

Volumn 7626, Issue , 2010, Pages

  Janzen, T ^a   Tavola, F ^b   Giussani, A ^a   Cantone, M C ^b   Uusijarvi H ^c   Mattsson, S ^c   Zankl, M ^a   Petoussi Henss N ^a   Hoeschen, C ^a  

^a INSTITUTE OF EPIDEMIOLOGY   (Germany)

^b UNIVERSITY OF MILAN   (Italy)

^c LUND UNIVERSITY   (Sweden)

Author keywords

18F choline; Model; PET; Prostate carcinoma

Indexed keywords

BIOKINETICS; BLOOD AND URINE SAMPLES; COMPARTMENTAL MODEL; COMPARTMENTAL MODELING; CT IMAGE; DATA COLLECTION; DIAGNOSTIC APPLICATIONS; FORCING FUNCTION; FUNCTIONAL IMAGING; HEALTHY TISSUES; POPULATION KINETICS; PROSTATE CANCERS; PROSTATE CARCINOMA; RADIOACTIVITY CONCENTRATION; SEPARATE UNIT; TEMPORAL VARIATION; TIME SCHEDULES;

BLOOD; COMPUTERIZED TOMOGRAPHY; DATA ACQUISITION; IMAGE QUALITY; OPTIMIZATION; POPULATION STATISTICS; THREE DIMENSIONAL;

MEDICAL IMAGING;

EID: 77953317342     PISSN: 16057422     EISSN: None     Source Type: Conference Proceeding    
DOI: 10.1117/12.844219     Document Type: Conference Paper

References (21)

1. Ackerstaff, E., et al. "Detection of increased choline compounds with proton nuclear magnetic resonance spectroscopy subsequent to malignant transformation of human prostatic epithelial.cells." Cancer Res. 61, 3599-3603 (2001). (Pubitemid 32694969)
2. Ackerstaff, E., et al. "Choline phospholipid metabolism: a target in cancer cells?" J Cell Biochem. 90, 525-33 (2003). (Pubitemid 37243700)
3. Macara, I.G., "Elevated phosphocholine concentration in ras-transformed NIH3T3 cells arises from increased choline kinase activity, not from phosphatidylcholine breakdown." Mol Cell Biol. 9, 325-328 (1989).
4. Ramirez de Molina, A., et al. "Overexpression of choline kinase is a frequent feature in human tumor-derived cell lines and in lung, prostate, and colorectal human cancers." Biochem Biophys Res Commun. 296, 580-583 (2002).
5. 18F labeled choline as an oncologic tracer for positron emission tomography: initial findings in prostate cancer." Cancer Res. 61, 110-117 (2000).
6. Husarik, D.B., et al. "Evaluation of [(18)F]-choline PET/CT for staging and restaging of prostate cancer." Eur J Nucl Med Mol Imaging. 35, 253-263 (2008).
7. 18F-fluorocholine PET." J Nucl Med. 47, 262-269 (2006).
8. 18F-fluorocholine PET/CT in the evaluation of prostate cancer recurrence." Nuklearmedizin. 48, 1-9 (2009).
9. Roivainen, A., et al. "Blood metabolism of [methyl-11C] choline: implications for in vivo imaging with positron emission tomography." Eur J Nucl Med. 27, 25-32 (2000). (Pubitemid 30097256)
10. 18F-Fluorocholine" J Nucl Med. 43, 92-96 (2002).
11. Sutinen, E., et al. "Kinetics of [11C] choline uptake in prostate cancer: a PET study." Eur J Nucl Med Mol Imaging. 31, 317-324 (2004).
12. 18F-choline studied in four prostate cancer patients" Accepted for publication in Rad Prot Dos. (2010).
13. Barrett, P.H.R., et al. "SAAM II: Simulation, analysis, and modeling software for tracer and pharmacokinetic studies" Metabolism. 47(4), 484-492 (1998).
14. D'Argenio, D.Z., Schumitzky, A. and Wang, X., "ADAPT 5 User's Guide: Pharmacokinetic/Pharmacodynamic Systems Analysis Software." Biomedical Simulations Resource, Los Angeles, (2009).
15. Audoly, S., et al. "Global identifiability of linear compartment models. A computer algebra algorithm." IEEE Trans. Biom. Eng. 4, 36-47 (1998).
16. 18F-choline" Third Malmö Conference on Medical Imaging (2009).
17. Foster, D.M., "Developing and testing integrated multicompartment models to describe a single-input multiple-output study using the SAAM II software system", [Clifford ed. "Mathematical Modeling of Experimental Nutrition"] Plenum Press, New York, 59-78, (1998).
18. ICRP Publication 67. Annals of the ICRP 23(3-4), (1993).
19. Noßke, D., Brix, G., "Dose assessment for C-11- and F-18-choline" SNM Annual Meeting, Toronto (2009).
20. ICRP Publication 53. Annals of the ICRP 18(1-4), (1987).
21. ICRP Publication 100. Annals of the ICRP 39(2), (2009).